Purpose: To describe the commissioning of AIRO mobile CT system (AIRO) for adaptive proton therapy on a compact double scattering proton therapy system.
these reasons that it is customary to include a range uncertainty margin on the proton beam to ensure that the target is covered. In our practice, a margin of 3% of the range is added plus an additional 3 mm to ensure adequate target coverage including uncertainties in the stopping power of the protons. When comparing two different CT scanners for dose comparison, any changes in the CT values and changes in the calculated stopping powers can lead to changes in the dose along the proton path or to a change in the range of the proton therapy.
The purpose of this study was to characterize the AIRO relative stopping power curve in preparation of adaptive proton therapy on a Mevion S250 compact double scattering proton therapy system and to assess the dosimetric implications of adaptive planning with the AIRO imaging system.
| MATERIALS AND METHODS

2.A | CT number comparison between AIRO and CT Sim
Images of an electron density CT phantom (Gammex RMI 467; Gammex Inc., Middlenton, WI, USA) containing 16 rods of 13 tissue substitute materials were acquired on the CT Sim and on the AIRO (Table 1) with varying plug patterns, table heights, and mA with fixed 120 kV. Thirteen images with various rod placements and table positions were averaged to acquire CT numbers (mean AE standard deviation). For each of the AIRO CT scans, the mobile CT scanner was moved into the proton treatment room and the proton treatment couch was used as the imaging couch top. Analysis of all images was performed in MIM v.6.6.7 software (MIM Software Inc, Cleveland, OH, USA). For each plug, in each scan, the average and standard deviation of the CT numbers for a 1 cm diameter region-of-interest (ROI) was acquired. The CT numbers for each plug were compared between the two different scanners. The CT constancy for the AIRO was also tested over several months for the clinically selected protocols.
Images were acquired for the following individual plugs: brain, lung 300, lung 450, cortical bone, adipose, breast, liver, solid water, and true water. The plugs were individually scanned in the Gammex phantom with solid water plugs in all other holes and with no plugs in the other holes to simulate the effect of lung-like scatter conditions ( Fig. 1 ). This study was performed to evaluate changes in the mean and standard deviations of each plug when scanned alone or with other plugs in place. The mean and standard deviations of the CT numbers were compared between the AIRO and the CT Sim to determine if there were differences in the CT number depending on the scanner used.
The Gammex RMI 467 was scanned as described above with the AIRO in the proton treatment room, as would be used for localization and/or adaptive scanning. To acquire SPRs, averaged CT numbers were entered into a stoichiometric SPR calculation algorithm.
The resulting AIRO SPR vs. CT number curve for scans (CT calibration curve) with 120 kV tube-voltage was entered into our Pinnacle treatment planning software v.16.0 (Philips Medical Systems, Fitchburg, WI, USA).
2.B | Treatment planning and dosimetric analysis
The last step of commissioning was to confirm the dosimetric equivalence for dose calculated on CT scans from the CT Sim and the AIRO. Treatment planning was done in Pinnacle using a double scatter beam module that had been previously commissioned for treatment planning. All treatment planning was done using the scans from the CT Sim with the clinically used CT Sim SPR curve. CT scans of a RANDO anthropomorphic thorax, pelvis, and head phantom as well as CIRS thorax and head phantoms were used for planning.
Heterogeneous, single-field, nonrobust plans were developed on each phantom in order to test the accuracy of dose for proton beams traversing large areas of heterogeneous media. Additionally, clinically realistic plans were generated to test the accuracy of the adaptive system for use in common clinical scenarios and to evaluate clinical metrics such as dose-volume histogram (DVH) changes between the two CT scans. Phantoms were used to ensure that dosimetric changes were only due to changes in the CT scan and not due to clinical changes in the images. Each phantom was scanned twice with AIRO in the proton treatment room.
Using the dynamic workflow module in the Pinnacle treatment planning system, the proton beams were locked from changes to the original, treatment planning CT scan and the beams were copied to the AIRO CT scans following rigid registration. Dose was calculated on the AIRO CT scans with whichever SPR curve was to be tested. To visually inspect the dosimetric comparison, the isodose lines from the treatment planning scan were converted to contours so they could be displayed on the AIRO CT scan. Dose was calculated on the AIRO CT scan using the following SPR curves: (a) CT Sim SPR curve, (b) AIRO-specific stoichiometric SPR curve (acquired in 2.A), and (c) dose-adjusted SPR curve (adjusted after visual inspection of isodose lines and CT numbers). To further compare the dosimetry between the treatment planning CT calculation and the AIRO CT calculation, gamma analysis of distance-to-agreement (DTA) and dose difference (DD) was performed using SNC patient software v.6.6 (Sun Nuclear Corporation, Melbourne, FL, USA). 13 The dose difference was chosen because it was a measure of the overall difference of the dose between the two CT calculations that should be the same. Because of the sharp fall-off in the dose at the distal edge of the beam, the distance-toagreement was also a good metric to evaluate the image registration between the two images and would be more sensitive to stopping power differences for the beam at the end of range. Each plan was assessed with the following criterion: 3%, 3 mm; 2%, 2 mm; and 1%, 1 mm. A gamma analysis of 1%, 1 mm was assessed to detect small variations in dose. However, larger criterion of 3%, 3 mm was assessed because clinically we utilize a 3% + 3 mm as our range uncertainty for proton plans. Also, this criterion for gamma analysis is utilized for IMRT QA and gives some clinical reference regarding the acceptability of comparing two different dose planes. [13] [14] [15] [16] Plans were evaluated at treatment isocenter in the coronal, sagittal, and transverse planes. All three stopping power curves (CT Sim, AIRO, and dose adjusted) were assessed and compared to the CT Sim plans. The dosimetry analysis for all plans was repeated on both AIRO scans.
2.B.1 | Nonclinical, heterogeneous plan details
For all phantoms, a treatment plan was developed with a single beam that traversed a heterogeneous portion of tissue. On the RANDO thorax phantom, one beam was placed that traversed both lungs and the heart with the end of range stopping in soft tissue. This change in CT numbers depending on plug configuration was most notable for the low-density plugs and also for the high-density plug. Most of the soft tissue plugs did not change with configuration. Table 2 is a summary of the mean and standard deviation of the CT numbers for each plug with different configurations.
2.B.2 | Clinically realistic plans
The final CT-SPR curves for the CT Sim and the AIRO are plotted in Fig. 3 . These curves appear similar although there are visible differences in the low CT number region (less than 800) and high CT number region (above 1400). Table 3 for the CT Sim, Stoichiometric AIRO, and doseadjusted SPR curves. WET for the beam on the pelvis RANDO phantom demonstrated results shown in Table 4 for the CT Sim, Stoichiometric AIRO, and dose-adjusted SPR curves. Average percent F I G . 2. Low-and high-density plug CT number comparison between AIRO and clinical CT Sim scanners. (a) Discrepancies for LN300 and LN450, (b) discrepancies for adipose, breast, solid water, brain, and liver, and (c) discrepancies for cortical bone. Solid water surround is shown in Fig. 1(a) . Air surround is shown in Fig. 1(b) . AIRO with dose-adjusted curve).
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3.B.3 | Nonclinical plans
The gamma analysis comparing the CT Sim treatment plan to each of the AIRO calculated plans for different gamma thresholds was averaged over the three planes passing through the beam isocenter (coronal, sagittal, and transverse). This was done to eliminate bias in the beam direction so the different plans on different phantoms could be compared. Data were also averaged between two AIRO CT scans for each phantom. A total of six different single beam plans were evaluated. Average percentage of passing points based on Gamma criteria of 1%,/1 mm, 2%/2 mm, and 3%,/3 mm are shown in Table 5 for the six different cases. Gamma analysis between the treatment plans and AIRO verification plans for single beam delivery showed that the dose-adjusted SPR curve was slightly better than the Stoichiometric AIRO curve; however, using the original treatment planning curve also yields good agreement. The relatively high passing rate for the dose-adjusted method indicates that calculated proton dose on AIRO image sets is sensitive enough to monitor dosimetric changes that warrant plan adaptation (Table 5) . the CIRS head phantom at 1%, 1 mm. Insignificant dose differences were found at 2%/2 mm or 3%/3 mm criteria for RANDO pelvis or RANDO head. At 3% and 3 mm, there were no difference in points passing in the CIRS lung or CIRS head phantom.
For a criteria of 3% and 3 mm, any of the SPR curves are sufficient (Table 6 ). However, we recommend that clinicians investigate the CT number variability in the low-density region and investigate the dosimetry in this region. Of note for the clinical plans, dose-volume histograms (DVHs) for structures of interest near the target volume showed no change from one SPR curve to another.
| DISCUSSION
This study shows that proton dose calculations on CT images sets from the AIRO mobile CT system can be used to calculate dose with relatively high accuracy similar to the clinically commissioned CT Sim. Therefore, in principle, the system can be used for adaptive proton treatment planning. Prior to this study, we developed many preliminary tests to determine which factors most affected the AIRO's CT numbers. 3 We tested various plug configurations, mA, table positions, reconstruction kernels, FOV, and phantoms. We found that reconstruction artifacts were minimal and that CT numbers were mostly affected by the surrounding materials and plug patterns. Thus, we decided to use the plug pattern suggested by Gammex when building the AIRO's SPR curve and we tested the AIRO CT numbers with various surrounding materials.
We found that AIRO HU values of both small lung plug volumes changed up to 6.3% (LN 450) when surrounded by solid water-which was not reproduced with our CT Sim (up to 1.7% difference). The reason for this phenomenon with AIRO scans is still unclear but could be related to the reconstruction of the images and beam hardening. This could also be related to the fact that the AIRO has bigger bore compared to a conventional CT simulator which introduces more scatter issues. The magnitude of these differences in air-like media is quanti- dose-adjusted SPR curve so that the agreement would be within 1-2 mm in the high-gradient region where the dose difference would be great. The failing points in the gamma analysis are mostly in the low-gradient region where the dose is different by >3% due to image noise and changes in the low-density region.
Our results demonstrated that performing the stoichiometric analysis for a given phantom and CT scan may not provide dose equivalence between two different CT scans. For the purposes of using an in-room CT for adaptive planning, it was important to verify the dosimetric equivalence of the two CT image sets with their corresponding stopping power curves. This was only achieved by directly mapping CT values and subsequently adjusting them to yield better dosimetric comparisons at the end of range. For robust proton beams (e.g., multiple beams, through less heterogeneity) with appropriate range uncertainty margins, the overall difference between the two CT images becomes less important.
At the time of writing this manuscript, the AIRO has been uti- 
CONCLUSI ONS
We present a methodology for developing a stopping power calibration curve on a new in-room AIRO mobile CT scanner for the purpose of adaptive proton therapy. Our methodology is based on reiterative dose-based mapping of SPR values between the clinically commissioned stationary CT scanner and AIRO for a variety of phantom, This approach yielded better overall dosimetric equivalency to the conventional stoichiometric method based on dose calculations in various heterogeneous phantoms. We show that the AIRO CT system can be a viable alternative to conventional CT Sim for the purpose of adaptive planning in proton therapy.
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